Cargando…

Benefit-cost analysis of coordinated strategies for control of rabies in Africa

Previous research suggests that dog mass vaccination campaigns can eliminate rabies locally, resulting in large human and animal life gains. Despite these demonstrated benefits, dog vaccination programs remain scarce on the African continent. We conducted a benefit-cost analysis to demonstrate that...

Descripción completa

Detalles Bibliográficos
Autores principales: Bucher, A., Dimov, A., Fink, G., Chitnis, N., Bonfoh, B., Zinsstag, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484917/
https://www.ncbi.nlm.nih.gov/pubmed/37679314
http://dx.doi.org/10.1038/s41467-023-41110-2
_version_ 1785102676904640512
author Bucher, A.
Dimov, A.
Fink, G.
Chitnis, N.
Bonfoh, B.
Zinsstag, J.
author_facet Bucher, A.
Dimov, A.
Fink, G.
Chitnis, N.
Bonfoh, B.
Zinsstag, J.
author_sort Bucher, A.
collection PubMed
description Previous research suggests that dog mass vaccination campaigns can eliminate rabies locally, resulting in large human and animal life gains. Despite these demonstrated benefits, dog vaccination programs remain scarce on the African continent. We conducted a benefit-cost analysis to demonstrate that engaging into vaccination campaigns is the dominant strategy for most countries even in the absence of coordinated action between them. And quantify how coordinated policy measures across countries in Africa could impact rabies incidence and associated costs. We show that coordinated dog mass vaccination between countries and PEP would lead to the elimination of dog rabies in Africa with total welfare gains of USD 9.5 billion (95% CI: 8.1 – 11.4 billion) between 2024 and 2054 (30 years). Coordinated disease control between African countries can lead to more socially and ecologically equitable outcomes by reducing the number of lost human lives to almost zero and possibly eliminating rabies.
format Online
Article
Text
id pubmed-10484917
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104849172023-09-09 Benefit-cost analysis of coordinated strategies for control of rabies in Africa Bucher, A. Dimov, A. Fink, G. Chitnis, N. Bonfoh, B. Zinsstag, J. Nat Commun Article Previous research suggests that dog mass vaccination campaigns can eliminate rabies locally, resulting in large human and animal life gains. Despite these demonstrated benefits, dog vaccination programs remain scarce on the African continent. We conducted a benefit-cost analysis to demonstrate that engaging into vaccination campaigns is the dominant strategy for most countries even in the absence of coordinated action between them. And quantify how coordinated policy measures across countries in Africa could impact rabies incidence and associated costs. We show that coordinated dog mass vaccination between countries and PEP would lead to the elimination of dog rabies in Africa with total welfare gains of USD 9.5 billion (95% CI: 8.1 – 11.4 billion) between 2024 and 2054 (30 years). Coordinated disease control between African countries can lead to more socially and ecologically equitable outcomes by reducing the number of lost human lives to almost zero and possibly eliminating rabies. Nature Publishing Group UK 2023-09-07 /pmc/articles/PMC10484917/ /pubmed/37679314 http://dx.doi.org/10.1038/s41467-023-41110-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bucher, A.
Dimov, A.
Fink, G.
Chitnis, N.
Bonfoh, B.
Zinsstag, J.
Benefit-cost analysis of coordinated strategies for control of rabies in Africa
title Benefit-cost analysis of coordinated strategies for control of rabies in Africa
title_full Benefit-cost analysis of coordinated strategies for control of rabies in Africa
title_fullStr Benefit-cost analysis of coordinated strategies for control of rabies in Africa
title_full_unstemmed Benefit-cost analysis of coordinated strategies for control of rabies in Africa
title_short Benefit-cost analysis of coordinated strategies for control of rabies in Africa
title_sort benefit-cost analysis of coordinated strategies for control of rabies in africa
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484917/
https://www.ncbi.nlm.nih.gov/pubmed/37679314
http://dx.doi.org/10.1038/s41467-023-41110-2
work_keys_str_mv AT buchera benefitcostanalysisofcoordinatedstrategiesforcontrolofrabiesinafrica
AT dimova benefitcostanalysisofcoordinatedstrategiesforcontrolofrabiesinafrica
AT finkg benefitcostanalysisofcoordinatedstrategiesforcontrolofrabiesinafrica
AT chitnisn benefitcostanalysisofcoordinatedstrategiesforcontrolofrabiesinafrica
AT bonfohb benefitcostanalysisofcoordinatedstrategiesforcontrolofrabiesinafrica
AT zinsstagj benefitcostanalysisofcoordinatedstrategiesforcontrolofrabiesinafrica